Browsing Harvard Medical School by Keyword "chronic myelogenous leukemia"
Now showing items 1-1 of 1
-
Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity
(Nature Publishing Group, 2013)Previous studies have demonstrated that p210 BCR/ABL1 interacts directly with the xeroderma pigmentosum group B (XPB) protein, and that XPB is phosphorylated on tyrosine in cells that express p210 BCR/ABL1. In the current ...